Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market

benzinga.com/analyst-stock-ratings/initiation/25/06/46081532/amylyx-eyes-2b-opportunity-in-post-surgery-sugar-crash-market

Guggenheim Partners on Monday initiated coverage on Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX), noting the company is poised to open post-bariatric hypoglycemia’s (PBH) blockbuster potential.
PBH is a common complication where blood sugar levels drop too low after meals in individuals…

This story appeared on benzinga.com, 2025-06-24 18:59:09.
The Entire Business World on a Single Page. Free to Use →